GUEST POST: This is a guest post by Anthony Stonefield, Co-founder & Executive Chairman of AutoRegenic Cell Laboratories (New York, New York). AutoRegenic Laboratories has developed an unique set of laboratory techniques, procedures and materials for producing patient-specific stem cells through nuclear transfer that is showing encouraging potential to become a practical, ethical and affordable approach for conducting spinal cord tissue re-origination.
He is a serial entrepreneur in innovations with 24 years of experience in venture development globally. [Read more…]
One of the ways to use market intelligence to analyze trends within the mesenchymal stem cell (MSC) market is to assess how the cell type is being discussed on leading social media platforms, such as Twitter.
